Cardinal Health, Inc. (CAH) to Issue Quarterly Dividend of $0.51 on October 15th

Cardinal Health, Inc. (NYSE:CAH – Get Free Report) announced a quarterly dividend on Thursday, August 15th, Zacks reports. Stockholders of record on Tuesday, October 1st will be given a dividend of 0.506 per share on Tuesday, October 15th. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.84%. The ex-dividend [...]

featured-image

Cardinal Health, Inc. ( NYSE:CAH – Get Free Report ) announced a quarterly dividend on Thursday, August 15th, Zacks reports. Stockholders of record on Tuesday, October 1st will be given a dividend of 0.

506 per share on Tuesday, October 15th. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.



84%. The ex-dividend date of this dividend is Tuesday, October 1st. This is an increase from Cardinal Health’s previous quarterly dividend of $0.

51. Cardinal Health has raised its dividend payment by an average of 1.0% annually over the last three years and has raised its dividend annually for the last 28 consecutive years.

Cardinal Health has a payout ratio of 26.5% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Cardinal Health to earn $8.

40 per share next year, which means the company should continue to be able to cover its $2.02 annual dividend with an expected future payout ratio of 24.0%.

Cardinal Health Stock Up 0.5 % Shares of NYSE CAH opened at $109.79 on Friday.

The business’s 50 day moving average is $107.10 and its two-hundred day moving average is $103.91.

Cardinal Health has a 52-week low of $85.82 and a 52-week high of $116.05.

The firm has a market cap of $26.74 billion, a price-to-earnings ratio of 48.80, a PEG ratio of 1.

33 and a beta of 0.60. Wall Street Analyst Weigh In CAH has been the subject of a number of research reports.

Evercore ISI lifted their price objective on shares of Cardinal Health from $105.00 to $115.00 and gave the company an “in-line” rating in a report on Thursday, August 15th.

Argus boosted their price target on shares of Cardinal Health from $115.00 to $125.00 and gave the stock a “buy” rating in a research note on Wednesday, September 11th.

JPMorgan Chase & Co. upped their price objective on Cardinal Health from $111.00 to $123.

00 and gave the stock a “neutral” rating in a research report on Wednesday, August 21st. UBS Group lifted their target price on Cardinal Health from $120.00 to $125.

00 and gave the company a “buy” rating in a report on Thursday, August 15th. Finally, Morgan Stanley upped their price target on Cardinal Health from $114.00 to $119.

00 and gave the stock an “overweight” rating in a report on Thursday, August 15th. One research analyst has rated the stock with a sell rating, four have issued a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.

com, the company has an average rating of “Moderate Buy” and an average price target of $119.36. View Our Latest Research Report on CAH Insider Transactions at Cardinal Health In related news, insider Jessica L.

Mayer sold 17,896 shares of the company’s stock in a transaction that occurred on Thursday, August 15th. The stock was sold at an average price of $106.48, for a total value of $1,905,566.

08. Following the completion of the transaction, the insider now directly owns 94,529 shares of the company’s stock, valued at $10,065,447.92.

The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website . In other Cardinal Health news, insider Jessica L. Mayer sold 17,896 shares of the firm’s stock in a transaction that occurred on Thursday, August 15th.

The shares were sold at an average price of $106.48, for a total transaction of $1,905,566.08.

Following the sale, the insider now owns 94,529 shares of the company’s stock, valued at $10,065,447.92. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website .

Also, CFO Aaron E. Alt sold 2,323 shares of the company’s stock in a transaction on Monday, August 19th. The shares were sold at an average price of $108.

91, for a total transaction of $252,997.93. Following the completion of the transaction, the chief financial officer now owns 36,867 shares of the company’s stock, valued at approximately $4,015,184.

97. The disclosure for this sale can be found here . In the last 90 days, insiders have sold 113,963 shares of company stock valued at $12,379,980.

Corporate insiders own 0.15% of the company’s stock. About Cardinal Health ( Get Free Report ) Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally.

It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. Recommended Stories Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter .

.